Living-donor kidney transplantation: comparison of robotic-assisted versus conventional open technique in obese recipients - Scorecard - MDSpire

Living-donor kidney transplantation: comparison of robotic-assisted versus conventional open technique in obese recipients

  • By

  • Alice Rondot

  • Stephan Levy

  • Jérémy Mercier

  • Anne Sophie Bajeot

  • Arnaud Del Bello

  • Nassim Kamar

  • Xavier Gamé

  • Nicolas Doumerc

  • Federico Sallusto

  • Thomas Prudhomme

  • February 18, 2026

  • 0 min

Share

Clinical Scorecard: Robotic-Assisted vs. Traditional Open Techniques in Living-Donor Kidney Transplantation for Obese Patients

At a Glance

CategoryDetail
ConditionEnd-stage renal failure in obese patients requiring kidney transplantation
Key MechanismsComparison of robotic-assisted kidney transplantation (RAKT) using da Vinci system versus conventional open kidney transplantation (OKT) focusing on intraoperative, postoperative, and functional outcomes
Target PopulationObese recipients (BMI ≥ 30 kg/m2) undergoing living donor kidney transplantation
Care SettingTertiary academic center performing living donor kidney transplantation

Key Highlights

  • RAKT enables precise intracorporeal vascular anastomosis with minimally invasive approach using the da Vinci Xi Surgical System.
  • Obese patients have higher postoperative complication risks including infections, hematoma, and thromboembolic events.
  • RAKT showed significantly shorter operative times compared to OKT with comparable intraoperative major complication rates.

Guideline-Based Recommendations

Diagnosis

  • Assess obesity using BMI ≥ 30 kg/m2 as defined by WHO.
  • Preoperative CT angiogram to evaluate for severe atherosclerotic plaques in external iliac vessels.
  • Exclude patients with complex abdominal surgeries or prior bilateral kidney transplantation for RAKT candidacy.

Management

  • Perform RAKT using a standardized transperitoneal approach with da Vinci Xi system following Vattikuti-Medanta technique.
  • OKT performed via conventional retroperitoneal Gibson incision technique.
  • Administer triple immunosuppression therapy including calcineurin inhibitor, steroids, and mycophenolic acid or mTOR inhibitor.
  • Induction therapy with basiliximab or antithymocyte globulin based on immunological risk.

Monitoring & Follow-up

  • Monitor for delayed graft function defined as dialysis requirement within first week post-transplant.
  • Assess postoperative complications using modified Clavien-Dindo classification, focusing on grade ≥ 3 for high-grade complications.
  • Evaluate graft function using estimated glomerular filtration rate (eGFR) calculated by CKD-EPI formula.

Risks

  • Increased risk of postoperative complications in obese patients including parietal complications, infections, hematoma, deep vein thrombosis, and pulmonary embolism.
  • Potential for intraoperative conversion from RAKT to open surgery due to bleeding or venous thrombosis.
  • Longer operative times associated with OKT compared to RAKT.

Patient & Prescribing Data

Obese living donor kidney transplant recipients eligible for robotic or open transplantation

RAKT offers a minimally invasive alternative with shorter operative times and comparable safety profile to OKT in obese patients; immunosuppression regimens remain consistent across techniques.

Clinical Best Practices

  • Careful patient selection for RAKT excluding those with complex abdominal history or severe iliac vessel atherosclerosis.
  • Utilize robotic-assisted techniques to reduce operative time and potentially minimize surgical trauma in obese recipients.
  • Standardize immunosuppression protocols and monitor closely for early graft function and postoperative complications.
  • Employ multidisciplinary surgical teams experienced in both robotic and open kidney transplantation techniques.

References

Original Source(s)

Related Content